Never Run Out Of Buyers To Sell To.

Early is Good is building a new category of diagnostics. Our breakthrough platform analyzes DNA, RNA, proteins and metabolites in a single test to find disease earlier than ever before. It does more than detect disease. It captures the full biological complexity behind it. We are not making diagnostics slightly better. We are redefining what it means to catch disease early with sensitivity far beyond today’s single omic tools and insights that drive confident clinical action. The mission is simple: Detect earlier. Treat smarter. Save lives.
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.